TReating Incontinence for Underlying Mental and Physical Health

NCT05362292 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

270

Enrollment

OTHER

Sponsor class

Conditions

Urinary Incontinence, Urge
Urinary Incontinence
Overactive Bladder
Incontinence, Urge
Incontinence, Urinary
Incontinence

Interventions

DRUG: Tolterodine Tartrate ER
DRUG: Mirabegron
DRUG: Placebo

Sponsor

University of California, San Francisco

Collaborators

[object Object]